Vietnam Pharmaceuticals Market Report and and Forecast 2026-2034

Study Period

2021-2034

Market (2025)

USD 7.8 Billion

Market (2034)

USD 13.98 Billion

CAGR

6.70%

Major Markets Players

DHG Pharmaceutical JSC, Traphaco JSC, Sanofi Vietnam, Abbott Laboratories Vietnam, GSK Vietnam and Others

*Note: Partial List Randomly Ordered

Vietnam Pharmaceuticals Market Insights & Analysis

The Vietnam Pharmaceuticals Market Market is anticipated to register a 6.70% during 2026-2034. The market size was valued at USD 7.8 Billion and is projected to reach USD 13.98 Billion by 2034.

The Vietnam Pharmaceuticals Market has witnessed steady growth over the past decade, driven by expanding healthcare infrastructure, rising healthcare expenditure, and increasing demand for advanced medical treatments. Vietnam’s rapidly growing population, combined with rising urbanization and improving living standards, has significantly contributed to the demand for pharmaceutical products. The country is experiencing an epidemiological transition where chronic diseases such as diabetes, cardiovascular disorders, and respiratory illnesses are becoming increasingly prevalent. This shift in disease patterns is driving demand for both prescription medications and preventive healthcare solutions. Additionally, the Vietnamese government has been actively investing in healthcare modernization programs aimed at improving hospital infrastructure, expanding insurance coverage, and strengthening domestic pharmaceutical manufacturing capabilities.

Furthermore, Vietnam has emerged as an attractive destination for pharmaceutical companies due to its growing healthcare market and favorable regulatory environment supporting foreign investment. The increasing presence of multinational pharmaceutical companies alongside domestic manufacturers has improved product availability and innovation within the market. Pharmaceutical companies are expanding their research capabilities and forming partnerships with local distributors to enhance market reach. Moreover, the rising adoption of digital healthcare platforms and telemedicine services is improving access to medicines and healthcare consultations, particularly in remote regions. These developments are expected to strengthen the pharmaceutical supply chain and enhance accessibility to essential medicines across Vietnam.

Vietnam Pharmaceuticals Market Dynamics

Key Driver: Rising Prevalence of Chronic Diseases and Expanding Healthcare Infrastructure

The increasing prevalence of chronic diseases is a major driver supporting the growth of the Vietnam Pharmaceuticals Market. Vietnam’s healthcare landscape is undergoing significant transformation as lifestyle changes, aging population trends, and urbanization contribute to a rising burden of non-communicable diseases. Conditions such as diabetes, cardiovascular diseases, cancer, and respiratory disorders are becoming increasingly common across the country. According to healthcare statistics, non-communicable diseases now account for more than 70% of total deaths in Vietnam. This growing disease burden has significantly increased demand for prescription medications, diagnostic services, and long-term treatment solutions.

In addition to rising disease prevalence, improvements in healthcare infrastructure are further accelerating pharmaceutical demand. The Vietnamese government has invested heavily in hospital expansion, medical equipment modernization, and healthcare workforce development. Public healthcare facilities are being upgraded while private healthcare providers are expanding their presence across major cities. The government’s universal healthcare initiatives are also improving access to essential medicines through expanded health insurance programs. These developments are strengthening pharmaceutical distribution networks and enabling greater access to advanced medical treatments. As healthcare infrastructure continues to expand, the demand for both branded and generic pharmaceutical products is expected to increase steadily.

Industry Trends: Growing Adoption of Generic Medicines and Expansion of Domestic Pharmaceutical Manufacturing

The Vietnam Pharmaceuticals Market is witnessing significant growth in the adoption of generic medicines due to their affordability and increasing government support for domestic drug production. Generic drugs play a crucial role in improving healthcare accessibility by offering cost-effective treatment options for a wide range of diseases. The Vietnamese government has implemented policies encouraging hospitals and healthcare providers to prioritize locally manufactured generic drugs in procurement processes. These initiatives are aimed at reducing dependency on imported medicines while strengthening the domestic pharmaceutical industry.

Another notable trend in the market is the expansion of domestic pharmaceutical manufacturing capacity. Several Vietnamese pharmaceutical companies are investing in modern production facilities that comply with international Good Manufacturing Practice (GMP) standards. These investments are enabling domestic manufacturers to produce high-quality pharmaceutical products that meet international regulatory requirements. Additionally, partnerships between local manufacturers and multinational pharmaceutical companies are facilitating technology transfer and research collaboration. These collaborations allow Vietnamese companies to enhance production capabilities and expand their product portfolios. As domestic pharmaceutical production continues to strengthen, Vietnam is gradually positioning itself as a regional pharmaceutical manufacturing hub.

Major Challenge: Regulatory Complexity and Dependence on Imported Pharmaceutical Ingredients

Despite strong market potential, the Vietnam Pharmaceuticals Market faces several challenges related to regulatory complexity and reliance on imported pharmaceutical raw materials. Pharmaceutical companies operating in Vietnam must comply with strict regulatory approval processes for drug registration, manufacturing, and distribution. Obtaining product approvals from regulatory authorities can be time-consuming, often requiring extensive documentation and compliance with local testing standards. These regulatory procedures may delay product launches and create operational challenges for pharmaceutical companies.

Another major challenge is the heavy reliance on imported active pharmaceutical ingredients (APIs) used in drug manufacturing. Vietnam imports a significant portion of its pharmaceutical raw materials from countries such as China and India. Supply chain disruptions or price fluctuations in these markets can directly affect domestic pharmaceutical production costs. Additionally, limited local research and development infrastructure may restrict the ability of domestic companies to develop innovative pharmaceutical products. Addressing these challenges will require increased investment in local pharmaceutical research capabilities and strengthened domestic supply chains.

Opportunity: Rising Demand for Digital Healthcare and Expansion of Online Pharmaceutical Distribution

The rapid growth of digital healthcare services presents significant opportunities for the Vietnam Pharmaceuticals Market. Telemedicine platforms and digital health applications are improving healthcare accessibility by enabling remote medical consultations and prescription management. These platforms allow patients to consult healthcare professionals online and receive digital prescriptions, which can then be fulfilled through licensed pharmacies. As internet penetration and smartphone adoption increase across Vietnam, digital healthcare services are expected to play an increasingly important role in pharmaceutical distribution.

Online pharmacies are also emerging as a promising distribution channel for pharmaceutical products. These platforms allow consumers to conveniently order prescription medications and over-the-counter drugs through secure online systems. The convenience of home delivery services and competitive pricing strategies offered by online pharmacies are encouraging more consumers to adopt digital purchasing channels. Additionally, pharmaceutical companies are leveraging digital marketing strategies and e-commerce platforms to expand their reach among tech-savvy consumers. As Vietnam continues to strengthen its digital infrastructure, the integration of online healthcare services is expected to significantly enhance pharmaceutical accessibility across the country.

Vietnam Pharmaceuticals Market Segment-wise Analysis

By Product Type:

• Prescription Drugs
• Over-the-Counter (OTC) Drugs
• Specialty Pharmaceuticals
• Others

Prescription drugs dominate the Vietnam Pharmaceuticals Market, accounting for nearly 64% of total market revenue. This dominance is primarily driven by the growing prevalence of chronic diseases and increasing demand for specialized medical treatments. Prescription medicines are widely used for managing long-term health conditions such as cardiovascular disorders, diabetes, cancer, and respiratory diseases. Hospitals and healthcare providers rely heavily on prescription drugs to treat complex medical conditions requiring physician supervision. In addition, government healthcare insurance programs often cover prescription medications for eligible patients, further supporting market demand.

Over-the-counter (OTC) drugs also represent a significant segment in the market due to their accessibility and convenience for treating minor health conditions. These products are commonly used to manage symptoms such as headaches, colds, allergies, and digestive disorders without requiring a doctor's prescription. OTC medications are widely available through retail pharmacies and drug stores, making them easily accessible for consumers. As health awareness increases among Vietnamese consumers, demand for preventive healthcare products and OTC medications is expected to grow steadily. The expansion of retail pharmacy networks across urban and rural areas is further strengthening the availability of pharmaceutical products nationwide.

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Hospital pharmacies represent the leading distribution channel in the Vietnam Pharmaceuticals Market, accounting for approximately 47% of total pharmaceutical sales. Hospitals remain the primary point of care for patients requiring prescription medications and specialized treatments. Public hospitals and private healthcare facilities play a crucial role in pharmaceutical procurement and distribution, particularly for prescription drugs used in chronic disease management. Hospital pharmacies are also responsible for dispensing medications prescribed by physicians during inpatient and outpatient treatments.

Retail pharmacies also hold a significant share of the pharmaceutical distribution network due to their accessibility and convenience for consumers. These pharmacies are widely distributed across urban neighborhoods and rural communities, providing easy access to both prescription and OTC medications. Meanwhile, online pharmacies are gradually gaining popularity as digital healthcare services expand across Vietnam. These platforms allow consumers to order medicines conveniently while benefiting from digital consultation services and home delivery options. As healthcare digitization continues to evolve, online pharmaceutical distribution channels are expected to play an increasingly important role in the market.

Regional Projection of Vietnam Pharmaceuticals Industry

• North Vietnam
• Central Vietnam
• South Vietnam
• Other Regions

South Vietnam leads the Vietnam Pharmaceuticals Market with an estimated market share of approximately 42%. The region's dominance is largely attributed to the presence of major economic centers such as Ho Chi Minh City, which hosts numerous healthcare institutions, pharmaceutical distributors, and research facilities. The region benefits from advanced healthcare infrastructure, strong pharmaceutical distribution networks, and higher consumer purchasing power compared to other parts of the country. Private healthcare providers and international pharmaceutical companies have also established significant operations in the region.

North Vietnam represents another important pharmaceutical market due to the presence of major healthcare institutions and government healthcare facilities in Hanoi. The region hosts several pharmaceutical manufacturing companies and research institutions involved in drug development and production. Meanwhile, Central Vietnam is gradually expanding its healthcare infrastructure through government investment and private sector participation. As healthcare services continue to improve across these regions, pharmaceutical demand is expected to grow steadily throughout Vietnam over the forecast period.

Why Choose This Report?

• Provides a comprehensive overview of the overall market analysis, encompassing key trends, consumer behavior analysis, and risk assessment to support strategic decision-making.
• Provides accurate, up-to-date insights into market size, segmentation, and emerging opportunities, helping to minimize risk & capitalizing on growth.
• Gives deep understanding of target audience preferences, investment habits, and communication channels for enhanced product development & marketing effectiveness.
• Delivers competitive analysis & benchmarking, uncovering the strengths & weaknesses of market competitors to guide strategies.
• Consolidate comprehensive market intelligence, reducing reasoning & streamlining research efforts.
• Facilitates customized market segmentation & risk mitigation strategies, fine-tuned to the business objectives.
• Aids in identifying both market challenges & untapped opportunities within the industry to drive long-term business growth.
• Provides valuable information based on actual customer data & search trends.